Luca Maggi
Luca Maggi has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Adrià Nicolàs-Aragó
Laboratory of Amino Acid Transporters and Disease, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Baldiri Reixac 10, 08028 Barcelona, Spain
1 shared publication Despoina Kapiki
Physical and Synthetic Biology, Faculty of Biology, Ludwig-Maximilians-Universität München , Großhadernerstr. 2-4, 82152 Planegg-Martinsried
1 shared publication- Els Pardon
VIB-VUB center for Structural Biology, VIB, pleinlaan 2, 1050 Brussels, Belgium
1 shared publication - Jan Steyaert
VIB-VUB center for Structural Biology, VIB, pleinlaan 2, 1050 Brussels, Belgium
1 shared publication - Joana Fort
Laboratory of Amino Acid Transporters and Disease, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Baldiri Reixac 10, 08028 Barcelona, Spain
1 shared publication - Manuel Palacín
Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain
1 shared publication
Latest Publications
- 24 February 2026
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 28 (10) , 6447-6456
Investigation of the non-ergodicity of protein dynamics
The study of microscopic protein dynamics has historically presented significant challenges for researchers seeking to develop a comprehensive and detailed description of its diverse and intriguing features.
- 24 February 2026
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 28 (10) , 6447-6456
Investigation of the non-ergodicity of protein dynamics
The study of microscopic protein dynamics has historically presented significant challenges for researchers seeking to develop a comprehensive and detailed description of its diverse and intriguing features.
- Open Access
- 23 December 2024
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 4 (1) , pgae584
The conserved lysine residue in transmembrane helix 5 is pivotal for the cytoplasmic gating of the L-amino acid transporters
L-Amino acid transporters (LATs) play a key role in a wide range of physiological processes. Defects in LATs can lead to neurological disorders and aminoacidurias, while the overexpression of these transporters is related to cancer. BasC is a bacterial LAT transporter with an APC fold. In this study, to monitor the cytoplasmic motion of BasC, we developed a single-molecule Förster resonance energy transfer assay that can characterize the conformational states of the intracellular gate in solution at room temperature. Based on combined biochemical and biophysical data and molecular dynamics simulations, we propose a model in which the conserved lysine residue in TM5 supports TM1a to explore both open and closed states within the cytoplasmic gate under apo conditions. This equilibrium can be altered by substrates, mutation of conserved lysine 154 in TM5, or a transport-blocking nanobody interacting with TM1a. Overall, these findings provide insights into the transport mechanism of BasC and highlight the significance of the lysine residue in TM5 in the cytoplasmic gating of LATs.
- 23 December 2024
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 4 (1) , pgae584
Open AccessThe conserved lysine residue in transmembrane helix 5 is pivotal for the cytoplasmic gating of the L-amino acid transporters
L-Amino acid transporters (LATs) play a key role in a wide range of physiological processes. Defects in LATs can lead to neurological disorders and aminoacidurias, while the overexpression of these transporters is related to cancer. BasC is a bacterial LAT transporter with an APC fold. In this study, to monitor the cytoplasmic motion of BasC, we developed a single-molecule Förster resonance energy transfer assay that can characterize the conformational states of the intracellular gate in solution at room temperature. Based on combined biochemical and biophysical data and molecular dynamics simulations, we propose a model in which the conserved lysine residue in TM5 supports TM1a to explore both open and closed states within the cytoplasmic gate under apo conditions. This equilibrium can be altered by substrates, mutation of conserved lysine 154 in TM5, or a transport-blocking nanobody interacting with TM1a. Overall, these findings provide insights into the transport mechanism of BasC and highlight the significance of the lysine residue in TM5 in the cytoplasmic gating of LATs.